A deal with drugmakers also means that Medicare would cover obesity drugs for the first time. But certain limitations persist ...

The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower the cost of GLP-1 drugs for many Americans.

US President Trump announced deals with Novo Nordisk (NVO) and Eli Lilly (LLY) to secure lower prices of the companies' GLP-1 ...

President Trump has announced a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for ...

A Novo Nordisk executive collapsed during President Trump’s announcement about lowering the cost of weight loss drugs like Wegovy and Ozempic. The executive received medical care and is now stable.

Donald Trump has unveiled a deal to slash the price of GLP-1 weight loss drugs by two thirds. The White House’s deal with Novo Nordisk and Eli Lilly will see the prices of WeGovy and Ozempic, also ...

US President Donald Trump has announced deals that aim to lower the cost of popular weight-loss drugs, as pharmaceutical prices take centre stage in his administration's messaging around affordability ...

U.S. President Donald Trump on Thursday struck deals with obesity drug manufacturers Eli Lilly and Novo Nordisk aimed at ...

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to reduce prices for their obesity ...